William A. Fischer

7.1k total citations · 2 hit papers
113 papers, 3.4k citations indexed

About

William A. Fischer is a scholar working on Infectious Diseases, Epidemiology and Emergency Medical Services. According to data from OpenAlex, William A. Fischer has authored 113 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 20 papers in Epidemiology and 17 papers in Emergency Medical Services. Recurrent topics in William A. Fischer's work include Viral Infections and Outbreaks Research (24 papers), Disaster Response and Management (16 papers) and Innovation and Knowledge Management (12 papers). William A. Fischer is often cited by papers focused on Viral Infections and Outbreaks Research (24 papers), Disaster Response and Management (16 papers) and Innovation and Knowledge Management (12 papers). William A. Fischer collaborates with scholars based in United States, Switzerland and Liberia. William A. Fischer's co-authors include Noel P. Greis, Gregory N. Stock, Jack N. Behrman, Subhashini A. Sellers, Frederick G. Hayden, Robert S. Hagan, David A. Wohl, Shevin T. Jacob, David J. Weber and Ilona Jaspers and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

William A. Fischer

100 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection

2017 294 citations Subhashini A. Sellers, William A. Fischer et al. profile →
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

2021 230 citations William A. Fischer, Joseph J. Eron et al. Science Translational Medicine profile →

Peers

Countries citing papers authored by William A. Fischer

Since Specialization

Citations

This map shows the geographic impact of William A. Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Fischer more than expected).

Fields of papers citing papers by William A. Fischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Fischer. The network helps show where William A. Fischer may publish in the future.

Co-authorship network of co-authors of William A. Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Fischer. A scholar is included among the top collaborators of William A. Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Fischer. William A. Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Research protocol design and implementation of a hybrid no-touch and low-touch prospective observational study during the COVID-19 public health emergency: the VISION study 2025 ·BMJ Public Health ·(unknown), Katie R. Mollan, Jessica Keys, (unknown), Ronald Swanstrom, Lakshmanane Premkumar, Timothy P. Sheahan, Shuntai Zhou, William A. Fischer, David A. Wohl	0
2	Development and Flight Tests of Wing-Mounted T/R Modules for a UAS-borne Multichannel VHF Ice Penetrating Radar 2025 ·(unknown), William A. Fischer, (unknown), (unknown), (unknown), (unknown), Mohammed Mahbubur Rahman, Amrita Sethi, Emily Arnold, Daniel Gómez-García, (unknown), (unknown), (unknown), Fernando Rodríguez‐Morales	0
3	Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative 2024 ·Journal of Clinical and Translational Science ·David A. Wohl, Stacey J. Adam, Kevin W. Gibbs, Ari Moskowitz, Thomas L. Ortel, Upinder Singh, Nikolaus Jilg, Teresa H. Evering, William A. Fischer, Babafemi Taiwo, Eric S. Daar, Christopher J. Lindsell, Susanna Naggie, Russell L. Rothman, Sarah E. Dunsmore, (unknown), (unknown), Dushyantha Jayaweera	1
4	COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina 2024 ·Journal of Antimicrobial Chemotherapy ·Heather Henderson, David A. Wohl, William A. Fischer, Luther A. Bartelt, David van Duin, (unknown), (unknown), (unknown), Amanda J Moy, Joseph J. Eron, Sonia Napravnik	2
5	Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic response 2024 ·Frontiers in Immunology ·Klaus Schughart, Amber M. Smith, Ephraim L. Tsalik, (unknown), Subhashini A. Sellers, William A. Fischer, Jens Schreiber, (unknown), Markus Cornberg, Jennifer Debarry, Christopher W. Woods, Micah T. McClain, Mark T. Heise	3
6	Development and Pilot of an Mpox Severity Scoring System 2023 ·The Journal of Infectious Diseases ·Jason Zucker, (unknown), (unknown), (unknown), (unknown), (unknown), Marshall J. Glesby, Timothy Wilkin, William A. Fischer, Inger K. Damon, John T. Brooks	8
7	Longitudinal SARS-CoV-2 Testing among the Unvaccinated Is Punctuated by Intermittent Positivity and Variable Rates of Increasing Cycle Threshold Values 2022 ·Microbiology Spectrum ·(unknown), Subhashini A. Sellers, (unknown), Jeremy D. Ward, (unknown), Herbert C. Whinna, William A. Fischer, Melissa B. Miller	2
8	Creation and impact of containment units with high-risk zones during the coronavirus disease 2019 (COVID-19) pandemic 2022 ·Infection Control and Hospital Epidemiology ·(unknown), (unknown), (unknown), (unknown), Shannon S. Carson, (unknown), (unknown), Lauren DiBiase, William A. Fischer, Katherine M. Schultz, Emily Sickbert-Bennett, (unknown), David J. Weber, (unknown), (unknown)	3
9	Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone 2021 ·Clinical Infectious Diseases ·(unknown), Donald S. Grant, (unknown), (unknown), (unknown), Michael Gbakie, Fatima Kamara, Lansana Kanneh, Ibrahim Mustapha, (unknown), William A. Fischer, David A. Wohl, Robert F. Garry, Robert J. Samuels, Jeffrey G. Shaffer, John S. Schieffelin	22
10	Rapid analysis of local data to inform off-label tocilizumab use early in the COVID-19 pandemic 2021 ·Healthcare ·Camille Morgan, Casey A. Rimland, (unknown), (unknown), (unknown), (unknown), (unknown), Heidi Swygard, Sonia Napravnik, John L. Schmitz, Shannon S. Carson, William A. Fischer, Joseph J. Eron, Cynthia L. Gay, Jonathan B. Parr	1
11	A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus breakdown → 2021 ·Science Translational Medicine ·William A. Fischer, Joseph J. Eron, Wayne Holman, Myron S. Cohen, Lei Fang, Laura J. Szewczyk, Timothy P. Sheahan, Ralph S. Baric, Katie R. Mollan, Cameron R. Wolfe, Elizabeth R. Duke, Masoud Azizad, Katyna Borroto–Esoda, David A. Wohl, Robert W. Coombs, Amy James Loftis, Paul Alabanza, (unknown), Wendy Painter	230
12	Ebola virus disease 2020 ·Nature Reviews Disease Primers ·Shevin T. Jacob, Ian Crozier, William A. Fischer, Angela Hewlett, Colleen S. Kraft, Marc-Antoine de La Vega, Moses J Soka, Victoria Wahl‐Jensen, Anthony Griffiths, Laura Bollinger, Jens H. Kuhn	353
13	ZMapp Reinforces the Airway Mucosal Barrier Against Ebola Virus 2018 ·The Journal of Infectious Diseases ·Bing Yang, Alison Schaefer, Yingying Wang, Justin McCallen, Phoebe Lee, Jay Newby, Harendra Arora, Priya A. Kumar, Larry Zeitlin, Kevin J. Whaley, Scott A. McKinley, William A. Fischer, (unknown), Samuel K. Lai	26
14	Age-Associated Changes in the Respiratory Epithelial Response to Influenza Infection 2018 ·The Journals of Gerontology Series A ·Kelly D. Chason, Ilona Jaspers, Joel S. Parker, Subhashini A. Sellers, (unknown), Sally A. Hunsucker, Paul M. Armistead, William A. Fischer	19
15	Global Burden of Influenza as a Cause of Cardiopulmonary Morbidity and Mortality 2014 ·Global Heart ·William A. Fischer, Michelle N. Gong, Satish Bhagwanjee, Jonathan Sevransky	66
16	Culturing of Human Nasal Epithelial Cells at the Air Liquid Interface 2013 ·Journal of Visualized Experiments ·Loretta Müller, Luisa E. Brighton, Johnny L. Carson, William A. Fischer, Ilona Jaspers	110
17	Hepatitis C Virus Infection Is Not An Independent Risk Factor For Obstructive Lung Disease 2013 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·William A. Fischer, Michael Drummond, Christian A. Merlo, David L. Thomas, Robert H. Brown, Shruti H. Mehta, Robert A. Wise, (unknown)	8
18	The critically ill child with novel H1N1 influenza A: A case series* 2010 ·Pediatric Critical Care Medicine ·Justin L. Lockman, William A. Fischer, Trish M. Perl, Alexandra Valsamakis, David G. Nichols	34
19	[Professional practice and theoretical orientation of women and men psychiatrists]. 1999 ·PubMed ·(unknown), William A. Fischer, (unknown), José Guimón	3
20	EXAMPLES OF REMOTE SENSING APPLICATIONS TO ENGINEERING 1969 ·Highway Research Board Special Report ·William A. Fischer	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact